| Pyridinyl derivatives as sodium channel activators |
2022-9-23 |
2023-3-30 |
|
| Pyridine derivatives and their use as sodium channel activators |
2022-9-23 |
2023-3-30 |
|
| Pyridinylacetamide derivatives as sodium channel activators |
2022-9-23 |
2023-3-30 |
|
| Methods for treating depressive disorders |
2022-6-06 |
2022-6-10 |
|
| Use of a kv7 potassium channel opener for treating pain |
2022-6-01 |
2022-8-01 |
|
| Ezogabine Potassium Channel Opener Immediate-Release Pediatric Formulation |
2022-5-27 |
2022-6-10 |
|
| Solid-state crystalline forms of a selective potassium channel modulator |
2022-5-05 |
2022-5-31 |
|
| Conjoint therapy for treating seizure disorders |
2022-2-09 |
2022-8-18 |
|
| Voltage-gated potassium channel opener for use in treating anhedonia |
2022-2-09 |
2022-8-18 |
|
| Solid state forms of spiro-oxindole compounds |
2022-2-04 |
2022-3-25 |
|
| Flunarizine for use in treating absence seizures |
2021-11-22 |
2022-5-27 |
|
| Methods for enhancing the bioavailability and exposure of a voltage-gated … |
2021-10-01 |
2022-3-03 |
|
| Benzenesulfonamide compounds and their use as therapeutic agents |
2021-9-01 |
2021-12-09 |
|
| Therapeutic compounds and methods of use thereof |
2021-8-06 |
2022-2-24 |
|
| Pharmaceutical formulations for treating diseases associated with voltage-gated … |
2021-4-09 |
2022-4-21 |
|
| Pharmaceutical formulations for treating diseases associated with voltage-gated … |
2021-4-09 |
2022-6-01 |
|
| HETEROARYL SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC … |
2021-2-25 |
2021-6-22 |
|
| Method to treat epilepsy |
2021-2-23 |
2021-4-30 |
|
| Substituted benzamides and methods of use thereof |
2021-1-19 |
2021-8-19 |
|
| Methods of treating pain |
2020-12-14 |
2021-7-15 |
|
| BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS |
2020-12-10 |
2021-5-28 |
|
| BENZENOSULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS |
2020-12-04 |
2021-3-15 |
|
| Therapeutic compounds and methods of use thereof |
2020-9-24 |
2021-6-10 |
|
| Substituted benzamides and methods of use thereof |
2020-9-03 |
2021-5-27 |
|
| Compounds for use in treating dravet syndrome and other disorders |
2020-6-26 |
2020-12-30 |
|
| Benzenesulfonamide compouds and their use as therapeutic agents |
2020-3-02 |
2021-11-16 |
2021-11-16 |
| Therapeutic compounds and methods of use thereof |
2019-12-03 |
2021-10-19 |
2021-10-19 |
| Substituted benzamides and methods of use thereof |
2019-11-07 |
2021-4-01 |
|
| Therapeutic compounds and methods of use thereof |
2019-9-19 |
2020-4-16 |
|
| Heteroaryl-substituted sulfonamide compounds and their use as sodium channel … |
2019-8-29 |
2020-3-05 |
|
| Substituted benzamides and methods of use thereof |
2018-9-17 |
2019-5-31 |
|
| N-substituted benzamides and methods of use thereof |
2018-8-07 |
2018-12-06 |
|
| Solid state forms of spiro-oxindole compounds |
2017-6-16 |
2022-7-01 |
|
| Asymmetric synthesis of funapide |
2017-6-16 |
2018-10-16 |
2018-10-16 |
| Spiro-oxindole compounds and their use as therapeutic agents |
2017-4-27 |
2017-5-18 |
|
| Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
2017-1-26 |
2017-3-30 |
|
| Pharmaceutical compositions of spiro-oxindole compound for topical … |
2017-1-10 |
2017-2-02 |
|
| Spiro-oxindole compounds and their use as therapeutic agents |
2017-1-05 |
2017-3-30 |
|
| Pyridazine derivatives and their use as therapeutic agents |
2016-12-23 |
2017-9-29 |
|
| N-substituted benzamide and use thereof for treatment of pain |
2016-11-01 |
2017-3-23 |
|
| THERAPEUTIC COMPOUNDS AND METHODS OF USE OF THE SAME |
2016-9-28 |
2017-12-20 |
|
| THERAPEUTIC COMPOUNDS AND THEIR METHODS OF USE |
2016-9-27 |
2018-8-08 |
|
| Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents |
2016-9-14 |
2017-3-09 |
|
| Synthetic methods for spiro-oxindole compounds |
2016-7-27 |
2016-8-18 |
|
| Substituted benzoxazoles and methods of use thereof |
2016-5-11 |
2017-1-13 |
|
| Substituted triazolopyridines and methods of use thereof |
2016-2-05 |
2016-7-08 |
|
| Methods of treating postherpetic neuralgia with a topical formulation of a … |
2016-2-05 |
2016-8-11 |
|
| Methods For Identifying Analgesic Agents |
2016-1-27 |
2016-6-16 |
|
| Spiro-oxindole compound and use thereof as therapeutic agent |
2016-1-25 |
2016-4-21 |
|
| Organic compounds |
2015-10-09 |
2016-10-06 |
|
| Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
2015-9-10 |
2017-6-15 |
2017-6-15 |
| Methods of treating pain associated with osteoarthritis of a joint with a … |
2015-2-05 |
2015-8-06 |
|
| SUBSTITUTED BENZAMIDS AND METHODS FOR USE |
2014-11-27 |
2016-6-01 |
|
| Biaryl ether sulfonamides and their use as therapeutic agents |
2014-11-21 |
2015-7-03 |
|
| Heterocyclic inhibitors of stearoyl-CoA desaturase |
2014-3-19 |
2015-11-17 |
2015-11-17 |
| Substituted benzoxazoles and methods of use thereof |
2014-3-14 |
2016-4-13 |
|
| Substituted benzoxazoles and methods of use thereof |
2014-3-14 |
2015-11-12 |
|
| Use of spiro-oxindole compound as therapeutic agent |
2013-9-30 |
2013-12-26 |
|
| Cyp8b1 and uses thereof in therapeutic and diagnostic methods |
2013-7-18 |
2014-1-30 |
|
| Organic compounds |
2013-7-15 |
2014-1-23 |
|
| Organic compounds |
2013-6-11 |
2016-6-23 |
2016-6-23 |
| N-substituted benzamides and their use in the treatment of pain |
2013-5-21 |
2016-3-31 |
|
| AMINOTHIAZOLE DERIVATIVE AS HUMAN STEAROYL-CoA DESATURASE INHIBITOR |
2013-3-05 |
2013-5-23 |
|
| Heterocyclic inhibitors of stearoyl-CoA desaturase |
2013-2-15 |
2013-3-07 |
|
| Heterocyclic derivative and use thereof as therapeutic agent |
2012-12-13 |
2013-3-21 |
|
| Benzenesulfonamide compounds and their use as therapeutic agents |
2012-10-30 |
2016-6-08 |
2016-6-08 |
| ヒトステアロイル−ＣｏＡデサチュラーゼを阻害するためのピリダジン誘導体 |
2012-10-18 |
2013-1-24 |
|